151 related articles for article (PubMed ID: 26743935)
1. Rhodium complexes as therapeutic agents.
Ma DL; Wang M; Mao Z; Yang C; Ng CT; Leung CH
Dalton Trans; 2016 Feb; 45(7):2762-71. PubMed ID: 26743935
[TBL] [Abstract][Full Text] [Related]
2. Group 9 organometallic compounds for therapeutic and bioanalytical applications.
Ma DL; Chan DS; Leung CH
Acc Chem Res; 2014 Dec; 47(12):3614-31. PubMed ID: 25369127
[TBL] [Abstract][Full Text] [Related]
3. Recent advances in biological activities of rhodium complexes: Their applications in drug discovery research.
Sohrabi M; Saeedi M; Larijani B; Mahdavi M
Eur J Med Chem; 2021 Apr; 216():113308. PubMed ID: 33713976
[TBL] [Abstract][Full Text] [Related]
4. Preparation of Rhodium(III) complexes with 2(1H)-quinolinone derivatives and evaluation of their in vitro and in vivo antitumor activity.
Lu X; Wu YM; Yang JM; Ma FE; Li LP; Chen S; Zhang Y; Ni QL; Pan YM; Hong X; Peng Y
Eur J Med Chem; 2018 May; 151():226-236. PubMed ID: 29614419
[TBL] [Abstract][Full Text] [Related]
5. Speciation of precious metal anti-cancer complexes by NMR spectroscopy.
Zou T; Sadler PJ
Drug Discov Today Technol; 2015 Sep; 16():7-15. PubMed ID: 26547416
[TBL] [Abstract][Full Text] [Related]
6. Organometallic anticancer complexes of lapachol: metal centre-dependent formation of reactive oxygen species and correlation with cytotoxicity.
Kandioller W; Balsano E; Meier SM; Jungwirth U; Göschl S; Roller A; Jakupec MA; Berger W; Keppler BK; Hartinger CG
Chem Commun (Camb); 2013 Apr; 49(32):3348-50. PubMed ID: 23505633
[TBL] [Abstract][Full Text] [Related]
7. CO-releasing binuclear rhodium complexes as inhibitors of nitric oxide generation in stimulated macrophages.
Moragues ME; Brines R; Terencio M; Sancenón F; Martínez-Máñez R; Alcaraz M
Inorg Chem; 2013 Dec; 52(24):13806-8. PubMed ID: 24279454
[TBL] [Abstract][Full Text] [Related]
8. Toward Multi-Targeted Platinum and Ruthenium Drugs-A New Paradigm in Cancer Drug Treatment Regimens?
Kenny RG; Marmion CJ
Chem Rev; 2019 Jan; 119(2):1058-1137. PubMed ID: 30640441
[TBL] [Abstract][Full Text] [Related]
9. Phosphoroorganic Metal Complexes in Therapeutics.
Demkowicz S; Kozak W; Daśko M; Rachon J
Mini Rev Med Chem; 2016; 16(17):1359-1373. PubMed ID: 27145849
[TBL] [Abstract][Full Text] [Related]
10. On the antitumor properties of novel cyclometalated benzimidazole Ru(II), Ir(III) and Rh(III) complexes.
Yellol GS; Donaire A; Yellol JG; Vasylyeva V; Janiak C; Ruiz J
Chem Commun (Camb); 2013 Dec; 49(98):11533-5. PubMed ID: 24177492
[TBL] [Abstract][Full Text] [Related]
11. Rhodium at the chemistry-biology interface.
Ohata J; Ball ZT
Dalton Trans; 2018 Oct; 47(42):14855-14860. PubMed ID: 30234200
[TBL] [Abstract][Full Text] [Related]
12. A multi-target caffeine derived rhodium(i) N-heterocyclic carbene complex: evaluation of the mechanism of action.
Zhang JJ; Muenzner JK; Abu El Maaty MA; Karge B; Schobert R; Wölfl S; Ott I
Dalton Trans; 2016 Aug; 45(33):13161-8. PubMed ID: 27334935
[TBL] [Abstract][Full Text] [Related]
13. Mitochondria-targeted cyclometalated rhodium(III) complexes: synthesis, characterization and anticancer research.
Peng YB; He W; Niu Q; Tao C; Zhong XL; Tan CP; Zhao P
Dalton Trans; 2021 Jul; 50(26):9068-9075. PubMed ID: 34113944
[TBL] [Abstract][Full Text] [Related]
14. A Perspective - can copper complexes be developed as a novel class of therapeutics?
Wehbe M; Leung AWY; Abrams MJ; Orvig C; Bally MB
Dalton Trans; 2017 Aug; 46(33):10758-10773. PubMed ID: 28702645
[TBL] [Abstract][Full Text] [Related]
15. Octahedral rhodium(III) complexes as kinase inhibitors: Control of the relative stereochemistry with acyclic tridentate ligands.
Mollin S; Riedel R; Harms K; Meggers E
J Inorg Biochem; 2015 Jul; 148():11-21. PubMed ID: 25660487
[TBL] [Abstract][Full Text] [Related]
16. The progresses in curcuminoids-based metal complexes: especially in cancer therapy.
Zhang Y; Khan AR; Fu M; Zhai Y; Yu A; Zhai G
Future Med Chem; 2019 May; 11(9):1035-1056. PubMed ID: 31140861
[TBL] [Abstract][Full Text] [Related]
17. Transition metal-α-amino acid complexes with antibiotic activity against Mycobacterium spp.
Karpin GW; Merola JS; Falkinham JO
Antimicrob Agents Chemother; 2013 Jul; 57(7):3434-6. PubMed ID: 23650159
[TBL] [Abstract][Full Text] [Related]
18. Recent development of transition metal complexes with in vivo antitumor activity.
Liang JX; Zhong HJ; Yang G; Vellaisamy K; Ma DL; Leung CH
J Inorg Biochem; 2017 Dec; 177():276-286. PubMed ID: 28641893
[TBL] [Abstract][Full Text] [Related]
19. Copper complexes as therapeutic agents.
Duncan C; White AR
Metallomics; 2012 Feb; 4(2):127-38. PubMed ID: 22187112
[TBL] [Abstract][Full Text] [Related]
20. Metal complexes in medicine with a focus on enzyme inhibition.
Che CM; Siu FM
Curr Opin Chem Biol; 2010 Apr; 14(2):255-61. PubMed ID: 20018553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
